http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1039847-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a9a05ec1fb027bb4a5cbe7f759d01aa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-9155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
filingDate 1998-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26566ed82836babd0041b6ba95646992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25704df7bc61e8ba257ff622aa04e6ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e7b7703e2a293e2155855ac0f14cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893d32cc0d5b364500f8a5f6487fb35b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aebce987b9e65c6a43e3e1381e6fc89
publicationDate 2000-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1039847-A1
titleOfInvention Vascular stent for reduction of restenosis
abstract Apparatus, and methods are provided for restoring, and maintaining an open passage or lumen (106) in a body conduit, such as a blood vessel, which has become stenosed or occluded. The apparatus includes a stent (100) which is specially adapted for inhibiting restenosis within the stent (100) after implantation in a body passage. In various embodiments, the apparatus also includes a catheter (120) or other device for operating the stent (100) to inhibit restenosis within the stented region of the body passage. The methods presented include implanting the stent (100) within a body passage, typically a blood vessel such as a coronary artery, which has become stenosed or occluded, and operating the stent (100) to inhibit ingrowth of stenotic material which would result in restenosis of the stented region. The stent (100) may be operated manually to inhibit or remove ingrowth of stenotic material, for example by introducing a catheter (120) which acts on the stent (100), or the stent (100) may operate automatically to inhibit or remove ingrowth of stenotic material without manual intervention.
priorityDate 1997-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26751

Total number of triples: 29.